Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-006291
Filing Date
2022-04-28
Accepted
2022-04-28 16:16:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220428xdefa14a.htm DEFA14A 20905
2 GRAPHIC tmb-20220428xdefa14a001.jpg GRAPHIC 265885
3 GRAPHIC tmb-20220428xdefa14a002.jpg GRAPHIC 215474
  Complete submission text file 0001558370-22-006291.txt   685098
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 22866777
SIC: 2834 Pharmaceutical Preparations